126 - Combination Products Collaboration, Turnover on MedTech/Pharma Project Teams, and Lessons from working with Intel's CEO with Mat Stratton, Founder of Coalition Ltd
Mat Stratton, Founder of Coalition Ltd, discusses his 20-year career in MedTech and combination products, highlighting his early work with Intel CEO Andy Grove on deep brain stimulation and drug delivery systems. He explains how the high-speed culture of Intel, driven by Grove's Parkinson's disease advocacy, contrasted with the slow 4-10 year cycles of medical device development. Stratton identifies 'multifunctional collaboration' and employee turnover as key bottlenecks, proposing solutions like 'two-pizza teams' and regulatory stewardship to accelerate progress in highly regulated industries.